These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27707051)

  • 1. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    Srivari Y; Chatterjee P
    J Microencapsul; 2016 Dec; 33(8):689-701. PubMed ID: 27707051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulation studies of betulinic acid with human serum albumin.
    Malleda C; Ahalawat N; Gokara M; Subramanyam R
    J Mol Model; 2012 Jun; 18(6):2589-97. PubMed ID: 22076062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns).
    Erukula SV; Srivari Y; Chatterjee P
    J Microencapsul; 2016 Sep; 33(6):524-534. PubMed ID: 27549905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betulinic acid binding to human serum albumin: a study of protein conformation and binding affinity.
    Subramanyam R; Gollapudi A; Bonigala P; Chinnaboina M; Amooru DG
    J Photochem Photobiol B; 2009 Jan; 94(1):8-12. PubMed ID: 18945624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
    Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
    Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part I. Albumin-bound betulinic acid nanoparticles (ABBns).
    J Microencapsul; 2016 Dec; 33(8):i-ii. PubMed ID: 28093010
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of betulinic acid nanoformulations.
    Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN
    Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.
    Li S; Zhang J; Fang Y; Yi J; Lu Z; Chen Y; Guo B
    Drug Des Devel Ther; 2020; 14():243-256. PubMed ID: 32021108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
    Wang R; Yang M; Li G; Wang X; Zhang Z; Qiao H; Chen J; Chen Z; Cui X; Li J
    Colloids Surf B Biointerfaces; 2019 Feb; 174():270-279. PubMed ID: 30469048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.
    Farcas CG; Dehelean C; Pinzaru IA; Mioc M; Socoliuc V; Moaca EA; Avram S; Ghiulai R; Coricovac D; Pavel I; Alla PK; Cretu OM; Soica C; Loghin F
    Int J Nanomedicine; 2020; 15():8175-8200. PubMed ID: 33122905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
    Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-incorporated albumin nanoparticles and its tumor image.
    Gong G; Pan Q; Wang K; Wu R; Sun Y; Lu Y
    Nanotechnology; 2015 Jan; 26(4):045603. PubMed ID: 25558927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells.
    Halder A; Jethwa M; Mukherjee P; Ghosh S; Das S; Helal Uddin ABM; Mukherjee A; Chatterji U; Roy P
    Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1362-1371. PubMed ID: 33284038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
    Valdés K; Morales J; Rodríguez L; Günther G
    Nanomedicine (Lond); 2016 Dec; 11(23):3139-3156. PubMed ID: 27809705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
    Jin X; Zhou J; Zhang Z; Lv H
    Int J Pharm; 2019 Nov; 571():118751. PubMed ID: 31605722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.